Thomas P Miller

  • 18820 Citations
  • 57 h-Index
1978 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1979 2016

  • 18820 Citations
  • 57 h-Index
  • 164 Article
  • 2 Chapter
  • 1 Letter
Filter
Letter
2016
25 Citations (Scopus)

Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Brown, J. R., Harb, W. A., Hill, B. T., Gabrilove, J., Sharman, J. P., Schreeder, M. T., Barr, P. M., Foran, J. M., Miller, T. P., Burger, J. A., Kelly, K. R., Mahadevan, D., Ma, S., Li, Y., Pierce, D. W., Barnett, E., Marine, J., Miranda, M., Azaryan, A., Yu, X. & 3 others, Nava-Parada, P., Mei, J. & Kipps, T. J., 2016, In : Haematologica. 101, 7, p. e295-e298

Research output: Contribution to journalLetter

B-Cell Chronic Lymphocytic Leukemia
N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide
Agammaglobulinaemia tyrosine kinase